Verovaccines Achieves Full Protection of Target Animals Against Viral Challenge in its 4th Animal Vaccine Program

4 March 2021 Validation of novel, cost-effective, multi-valent animal vaccines with high safety and efficacy Results extend usability of the Company’s platform in the poultry sector Progeny fully protected against viral infection Read more

2021, Feb 9-12: EuroTier digital

9 February 2021 EuroTier in Hannover is the world’s largest trade fair for animal husbandry and management. We look forward to meeting you online and talking about new products and innovations.

Eligibility of investor investments under the BMWi’s INVEST programm

30 November 2020 Verovaccines GmbH receives BAFA certification that it meets all the requirements for eligible investor participation. This means that investors can benefit from an acquisition grant and an exit grant when investing in the company. https://www.bmwi.de/Redaktion/DE/Dossier/invest.htm

2020, Dec 15: Animal Health Innovation Conference

15 December 2020 Animal Health Innovation Conference The Animal Health Innovation Europe (22-23 Feb 2021) is an international conference to network with innovators in animal health and nutrition and connecting those businesses with financial investors and strategic corporate partners. Meet us there!

2020, Nov 12-14: 98th and 99th Symposium on Poultry Diseases, online

12 October 2020 Prof. Dr. Sven-Eik Behrens, Managing Director of Verovaccines GmbH, will give a presentation on successful subunit vaccination with a new yeast-based vaccination concept at the DVG-organised expert meeting on poultry diseases on 13 November 2020.

2020, Oct 20-21: PDA Europe Virtual Conference – Aseptic Animal Health, online

20 September 2020 At the PDA Europe Virtual Conference – Aseptic Animal Health, Dr. Hanjo Hennemann, managing director of Verovaccines GmbH, gives an invited talk about K. lactis-based subunit vaccines. He explains technology and validation of this novel vaccine class in animal health. The Parenteral Drug Association (PDA) is a non-profit organization, committed to developing […]

Vaccine developer Verovaccines concludes further pharmaceutical cooperation

11 February 2020 Verovaccines GmbH concludes the second cooperation with an internationally operating veterinary pharmaceutical company The cooperation aims at the joint development of a veterinary vaccine based on the proprietary technology platform Read more

2020, Jan 15: Animal Health Investment Europe, London

15 December 2019 Animal Health Investment Europe (24-26 February, 2020) is an investment forum showcasing the investment opportunities in animal health and nutritional health, and connecting those businesses with financial investors and strategic corporate partners from 38 countries worldwide.Meet us there!

Verovaccines concludes international pharma cooperation agreement

3 December 2019 Verovaccines enters into first collaboration with a Japanese pharmaceutical company to jointly develop a veterinary vaccine The goal is to develop and commercialize novel, cost-effective vaccines with high safety and efficacy for animal health The company was financed for the seed phase by High-Tech Gruenderfonds, Business Angels and the founders as well […]

2019, Oct. 1-2: Animal AgTech Innovation Summit, Amsterdam

1 September 2019 The Animal AgTech Innovation Summit will gather leaders of international agribusinesses, livestock producers, animal health and feed companies with technology providers, entrepreneurs and investors – Meet us there!